Blood protein may help track disease activity in people with aHUS

Researchers have identified that levels of the blood protein subunit FXIII-B may serve as a biomarker for tracking disease activity in patients with atypical hemolytic uremic syndrome (aHUS). The study suggests that monitoring these protein patterns could help distinguish between acute episodes and remission.